Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Hematology Oncology Consultants.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Ortho Biotech, Inc.
Information provided by:
Hematology Oncology Consultants
ClinicalTrials.gov Identifier:
NCT00159094
First received: September 7, 2005
Last updated: May 30, 2008
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given